The Global Health & Development Group aims to harness the skills and expertise of its technical and managerial staff to contribute to better health around the world through more effective and equitable use of resources.

The team is made up of health economists, technical analysts, advisors, project management and communications staff and provides advice and support to low and middle-income countries (LMICs) on the use of evidence in making clinical and policy decisions.

We strive to have a positive influence on health policies and programmes on an international scale and to date, we have engaged with governments and providers in over 60 countries on how to obtain value for money from their healthcare budgets.

Under the leadership of Professor Kalipso Chalkidou, the GHD Group is the Secretariat of the International Decision Support Initiative (iDSI), which provides expert advice to decision-makers in LMICs to support them make evidence-informed decisions about how much public money to spend on healthcare; and how that money can be spent as effectively as possible. iDSI is a global network of expertise with partners in South Africa, China, USA and Thailand all working together to provide tailored support to countries we engage with. iDSI’s driving force is the belief that everyone should have fair access to health, receiving the right treatment and the right medicines at the right time.

Our current engagement includes: working with the Ministry of Health in Kenya to explore scaling up access to antiretroviral therapy; supporting the Ministry of Health and Family Welfare in India to train community healthcare staff in India to implement evidence-based guidelines for diabetes and hypertension; and training hospital staff in Vietnam to implement pneumonia quality standards.

iDSI receives funding from the Bill & Melinda Gates Foundation and the Department for International Development.